acitretin has been researched along with Eczema, Atopic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batashki, I; Kordeva, SA; Tchernev, G | 1 |
| Bergman, P; Ehrström, M; Eidsmo, L; Lysell, J; Padhi, A; Ramesh, A; Simon, M; Sonkoly, E; Srivastava, A | 1 |
| Antiga, E; Caproni, M; Cardilicchia, E; Fabbri, P; Filì, L; Maggi, L; Manuelli, C; Parronchi, P; Volpi, W | 1 |
| Anton-Lamprecht, I; Blaschke, S; Hausser, I; Möller, R; Paul, E | 1 |
1 review(s) available for acitretin and Eczema, Atopic
| Article | Year |
|---|---|
[Comèl-Netherton syndrome].
Topics: Acitretin; Adult; Chromosome Aberrations; Chromosome Disorders; Dermatitis, Atopic; Diagnosis, Differential; Female; Genes, Recessive; Hair Diseases; Humans; Ichthyosis, Lamellar; Microscopy, Electron; Skin | 1998 |
3 other study(ies) available for acitretin and Eczema, Atopic
| Article | Year |
|---|---|
Netherton syndrome in a Bulgarian patient : Presentation of a case and an update of therapeutic options.
Topics: Acitretin; Adolescent; Bulgaria; Dermatitis, Atopic; Erythrokeratodermia Variabilis; Humans; Netherton Syndrome | 2023 |
IL-22 Downregulates Peptidylarginine Deiminase-1 in Human Keratinocytes: Adding Another Piece to the IL-22 Puzzle in Epidermal Barrier Formation.
Topics: Acitretin; Biopsy; Cell Differentiation; Cell Line; Citrullination; Dermatitis, Atopic; Down-Regulation; Epidermis; Filaggrin Proteins; Humans; Interleukin-22; Interleukins; Keratin-1; Keratinocytes; Primary Cell Culture; Protein-Arginine Deiminase Type 1; Psoriasis; Vitamin D | 2022 |
Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.
Topics: Acitretin; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; CD8-Positive T-Lymphocytes; Dermatitis, Atopic; Down-Regulation; Drug Administration Schedule; Etanercept; Female; Humans; Immunoglobulin G; Interleukin-10; Interleukin-17; Keratolytic Agents; Lymphocyte Count; Male; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Signal Transduction; Skin; Th1 Cells; Th17 Cells; Th2 Cells; Treatment Outcome | 2012 |